Skip to main content
Top
Published in: Clinical Rheumatology 3/2011

01-03-2011 | Letter to the Editor

Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis

Authors: Bruno Seriolo, Luigi Molfetta, Maurizio Cutolo

Published in: Clinical Rheumatology | Issue 3/2011

Login to get access

Excerpt

Sir, …
Literature
1.
go back to reference Caramaschi P, Dalla Gassa A, Ruzzenente O et al (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29:1419–1425PubMedCrossRef Caramaschi P, Dalla Gassa A, Ruzzenente O et al (2010) Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol 29:1419–1425PubMedCrossRef
2.
go back to reference Vacca A, Cormier C, Piras M et al (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36:1924–1929PubMedCrossRef Vacca A, Cormier C, Piras M et al (2009) Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 36:1924–1929PubMedCrossRef
3.
go back to reference Calzolari G, Data V, Carignola R et al (2009) Hypovitaminosis D in systemic sclerosis. J Rheumatol 36:2844PubMedCrossRef Calzolari G, Data V, Carignola R et al (2009) Hypovitaminosis D in systemic sclerosis. J Rheumatol 36:2844PubMedCrossRef
4.
Metadata
Title
Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis
Authors
Bruno Seriolo
Luigi Molfetta
Maurizio Cutolo
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1684-7

Other articles of this Issue 3/2011

Clinical Rheumatology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.